The revised Schedule M is both a challenge and an opportunity for India’s pharmaceutical sector.... Jan 02
As the industry continues to grow and evolve, it promises to transform healthcare and meet its needs.... Dec 20
Latest pharma news update... Dec 30
Manufacturing agreement is for Vivet’s Investigational Gene Therapy for Wilson Disease... Sep 24
Novavax aims for 2 billion COVID-19 vaccine doses with expanded Serum Institute, India deal ... Sep 16
GIGA-2050 is a new class of drug designed to provide passive immunity to COVID-19 patients or those at high risk.... Sep 16
-Advertisements-